XERS fund manager activity
Xeris Biopharma Holdings, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q4 2021 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Trimmed | 35,412 | $277,984 | 0.00% | Feb 17, 2026 |
| Polen Capital Management | Added | 133,416 | $1,047,316 | 0.00% | Feb 12, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Added | 42,741 | $347,912 | 0.00% | Nov 14, 2025 |
| Polen Capital Management | Added | 133,191 | $1,084,175 | 0.00% | Nov 12, 2025 |